Weon Kim Selected Research

Nicorandil (SG 75)

10/2013	Effect of nicorandil on clinical outcomes in patients with ST-segment elevation and non-ST-segment elevation myocardial infarction: based on the Korea Acute Myocardial Infarction Registry (KAMIR).
6/2012	Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
11/2006	The changes of fractional flow reserve after intracoronary nitrate and Nicorandil injection in coronary artery ectasia.
3/2005	Myocardial protective effects of nicorandil during percutaneous coronary intervention in patients with unstable angina.
10/2004	Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weon Kim Research Topics

Disease

45	Myocardial Infarction 12/2023 - 03/2003
24	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 09/2003
13	Coronary Artery Disease (Coronary Atherosclerosis) 03/2022 - 12/2004
13	Hyperplasia 12/2019 - 07/2003
12	Thrombosis (Thrombus) 02/2023 - 10/2004
12	Death (Near-Death Experience) 01/2023 - 09/2003
10	Reperfusion Injury 10/2020 - 02/2012
9	Hemorrhage 01/2023 - 09/2003
9	Inflammation (Inflammations) 03/2022 - 06/2007
9	Ischemia 06/2020 - 03/2007
8	Pathologic Constriction (Stenosis) 08/2022 - 12/2003
7	Hypertension (High Blood Pressure) 07/2023 - 04/2013
7	Acute Coronary Syndrome 01/2023 - 09/2003
7	Heart Failure 03/2022 - 10/2004
7	Hypercholesterolemia 01/2022 - 10/2016
6	Essential Hypertension 05/2024 - 05/2009
6	Infarction (Infarctions) 04/2024 - 09/2013
6	ST Elevation Myocardial Infarction 01/2021 - 09/2013
5	Atherosclerosis 12/2023 - 11/2012
4	Diabetes Mellitus 12/2022 - 09/2003
4	Cardiotoxicity 03/2022 - 04/2017
4	Atrial Fibrillation 12/2021 - 01/2016
4	Stroke (Strokes) 12/2021 - 01/2016
4	Chronic Kidney Failure (Chronic Renal Failure) 07/2017 - 11/2009
4	Coronary Restenosis 10/2007 - 12/2004
3	Dyslipidemias (Dyslipidemia) 12/2023 - 01/2022
3	Neointima 12/2020 - 10/2007
3	Chronic Renal Insufficiency 03/2020 - 11/2010
3	Insulin Resistance 01/2019 - 05/2009
3	Hypoxia (Hypoxemia) 01/2017 - 08/2010
3	Unstable Angina 03/2005 - 09/2003
2	Drug-Related Side Effects and Adverse Reactions 01/2023 - 01/2018
2	Hypertriglyceridemia 11/2022 - 03/2022
2	Stable Angina 08/2022 - 03/2014
2	Necrosis 03/2022 - 06/2012
2	Neoplasms (Cancer) 03/2022 - 10/2017
2	Fibrosis (Cirrhosis) 01/2022 - 08/2008
2	Ventricular Remodeling 10/2020 - 07/2019
2	Cardiomyopathies (Cardiomyopathy) 09/2020 - 01/2016
2	Left Ventricular Dysfunction 07/2019 - 04/2017
2	Wounds and Injuries (Trauma) 01/2019 - 07/2003

Drug/Important Bio-Agent (IBA)

13	omega-Chloroacetophenone (Mace)IBA 01/2022 - 09/2003
10	LipidsIBA 12/2023 - 10/2016
10	Rosuvastatin Calcium (Crestor)FDA Link 07/2023 - 06/2007
9	Clopidogrel (Plavix)FDA Link 10/2020 - 11/2009
9	Abciximab (ReoPro)FDA Link 03/2010 - 10/2004
7	Ezetimibe (Zetia)FDA Link 07/2023 - 10/2016
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 12/2005
5	Phenobarbital (Luminal)FDA Link 08/2022 - 09/2003
5	C-Reactive ProteinIBA 01/2019 - 03/2003
5	Exenatide (Byetta)FDA Link 05/2017 - 02/2012
5	Nicorandil (SG 75)IBA 10/2013 - 10/2004
4	Amlodipine (Norvasc)FDA LinkGeneric 05/2024 - 09/2018
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 04/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 04/2017
4	TicagrelorIBA 10/2020 - 06/2015
4	Substance PIBA 06/2020 - 11/2018
4	erucylphosphocholineIBA 08/2015 - 03/2007
3	Soluble Guanylyl CyclaseIBA 03/2022 - 01/2017
3	CholesterolIBA 01/2022 - 01/2018
3	oxidized low density lipoproteinIBA 01/2022 - 01/2015
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 03/2007
3	Cytochrome P-450 CYP2C19IBA 12/2021 - 01/2018
3	NitratesIBA 01/2021 - 10/2004
3	salicylhydroxamic acid (SHAM)IBA 06/2020 - 01/2017
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 04/2013
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2006 - 09/2003
3	Dalteparin (Dalteparin Sodium)FDA Link 11/2006 - 09/2003
3	Heparin (Liquaemin)FDA LinkGeneric 11/2006 - 09/2003
3	Platelet Membrane GlycoproteinsIBA 03/2006 - 12/2004
2	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 01/2020
2	PolymersIBA 12/2022 - 01/2018
2	Sirolimus (Rapamycin)FDA Link 12/2022 - 06/2007
2	Telmisartan (Micardis)FDA Link 10/2022 - 05/2009
2	Lipoprotein(a)IBA 03/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2020
2	Caspase 8 (Caspase-8)IBA 01/2022 - 12/2019
2	CalciumIBA 01/2022 - 03/2016
2	Toll-Like Receptor 2IBA 01/2022 - 12/2019
2	AnticoagulantsIBA 09/2021 - 01/2016
2	Dabigatran FDA Link 09/2021 - 01/2016
2	RivaroxabanIBA 09/2021 - 01/2016
2	Warfarin (Coumadin)FDA LinkGeneric 09/2021 - 01/2016
2	N(4)-oleylcytosine arabinosideIBA 09/2021 - 01/2016
2	Ergonovine (Ergometrine)IBA 01/2021 - 11/2010
2	Troponin IIBA 07/2020 - 09/2013
2	AdiponectinIBA 01/2019 - 04/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2019 - 06/2007
2	Adenosine Triphosphate (ATP)IBA 10/2016 - 02/2012
2	HDL CholesterolIBA 05/2016 - 01/2016

Therapy/Procedure

32	Percutaneous Coronary Intervention 04/2024 - 03/2003
31	Stents 01/2023 - 07/2003
20	Therapeutics 05/2024 - 09/2003
4	Drug-Eluting Stents 12/2022 - 10/2007
4	Electroacupuncture 07/2017 - 01/2015
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 01/2016
3	Renal Dialysis (Hemodialysis) 07/2017 - 01/2015
3	Aftercare (After-Treatment) 09/2015 - 05/2009
2	Electric Countershock (Cardioversion) 12/2021 - 05/2011